These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 6812710)
1. Myopathy due to mercaptopropionyl glycine. Mansell MA Br Med J (Clin Res Ed); 1982 Nov; 285(6351):1356-7. PubMed ID: 6812710 [No Abstract] [Full Text] [Related]
2. Myopathy due to mercaptopropionyl glycine. Hales DS; Scott R; Lewi HJ Br Med J (Clin Res Ed); 1982 Oct; 285(6346):939. PubMed ID: 6811078 [No Abstract] [Full Text] [Related]
6. Mercaptopropionylglycine: a progress in cystine stone therapy. Hautmann R; Terhorst B; Stuhlsatz HW; Lutzeyer W J Urol; 1977 May; 117(5):628-30. PubMed ID: 870714 [TBL] [Abstract][Full Text] [Related]
7. Nephrotic syndrome during treatment with alpha-mercaptopropionylglycine. Rizzoni G; Pavanello L; Dussini N; Chiandetti L; Zacchello G J Urol; 1979 Sep; 122(3):381-2. PubMed ID: 470014 [TBL] [Abstract][Full Text] [Related]
8. Comparison of 2-mercaptopropionylglycine and D-penicillamine in the treatment of cystinuria. Harbar JA; Cusworth DC; Lawes LC; Wrong OM J Urol; 1986 Jul; 136(1):146-9. PubMed ID: 3712602 [TBL] [Abstract][Full Text] [Related]
9. 2-Mercaptopropionate, a novel metabolite formed during treatment with 2-mercaptopropionyl-glycine in cystinuria. Mårtensson J; Denneberg T; Kågedal B Eur J Clin Pharmacol; 1986; 31(1):119-21. PubMed ID: 3780820 [TBL] [Abstract][Full Text] [Related]
10. A case of nephrotic syndrome due to alpha-mercaptopropionyl glycine in a patient with familial cystinuria. Shibasaki T; Murai S; Kodama K; Nakano H; Ishimoto F; Sakai O Nihon Jinzo Gakkai Shi; 1990 Aug; 32(8):933-7. PubMed ID: 2250412 [TBL] [Abstract][Full Text] [Related]
11. Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine. Pak CY; Fuller C; Sakhaee K; Zerwekh JE; Adams BV J Urol; 1986 Nov; 136(5):1003-8. PubMed ID: 3534301 [TBL] [Abstract][Full Text] [Related]
12. [Myasthenia caused by tiopronin during treatment of rheumatoid polyarthritis]. Menkes CJ; Job-Deslandre C; Bauer-Vinassac D; Rouillon A; Rousseau R Presse Med; 1988 Jun; 17(22):1156-7. PubMed ID: 2969543 [No Abstract] [Full Text] [Related]
17. Thiopronine-induced pemphigus vulgaris in rheumatoid arthritis. Trotta F; Scaramelli M; Cervi G; Virgili AR Scand J Rheumatol; 1984; 13(1):93-5. PubMed ID: 6719065 [TBL] [Abstract][Full Text] [Related]
18. Lupus like syndrome induced by 2-mercaptopropionylglycine. Katayama I; Nishioka K J Dermatol; 1986 Apr; 13(2):151-3. PubMed ID: 3531274 [No Abstract] [Full Text] [Related]
19. Drug-induced bullous lichen planus in a patient with diabetes mellitus and liver disease. Hsiao L; Yoshinaga A; Ono T J Am Acad Dermatol; 1986 Jul; 15(1):103-5. PubMed ID: 3522669 [No Abstract] [Full Text] [Related]
20. Tiopronin (N-[2-mercaptopropionyl] glycin) in rheumatoid arthritis. Amor B; Mery C; de Gery A Arthritis Rheum; 1982 Jun; 25(6):698-703. PubMed ID: 7046758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]